Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined With Tislelizumab, Liposomal Irinotecan, and Capecitabine in the Treatment of pMMR Locally Advanced Rectal Adenocarcinoma With Low Rectal Involvement

Abroad (travel likely)RecruitingPHASE2

Conditions

Rectal Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Shantou University Medical College Cancer Hospital, Shantou, Guangdong, China

  • The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China

    Contact: Study coordinator (Xinxin Li) · Savageli23@163.com · +86-135-3126-8157